SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-039443
Filing Date
2023-11-06
Accepted
2023-11-06 08:05:11
Documents
14
Period of Report
2023-11-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 54112
2 ex10-1.htm EX-10.1 301688
3 ex10-2.htm EX-10.2 123688
  Complete submission text file 0001493152-23-039443.txt   747453

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE envb-20231103.xsd EX-101.SCH 3012
5 XBRL LABEL FILE envb-20231103_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE envb-20231103_pre.xml EX-101.PRE 22357
8 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3443
Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

IRS No.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38286 | Film No.: 231378177
SIC: 2834 Pharmaceutical Preparations